PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
December 2, 2025Cell & Bioscience2 citationsOpen Access

RNF186 controls glucose metabolism in metabolic dysfunction-associated fatty liver disease

View Full Paper
QDQizhang Du

Key Points

  • Glucose metabolism is influenced by RNF186 in metabolic dysfunction-associated fatty liver disease.
  • The mechanism involves the transcription and translocation of GLUT4 in skeletal muscle.
  • Transcriptional modulation by RNF186 suggests a direct therapeutic target for metabolic disorders.
  • The findings point to the potential therapeutic strategy targeting RNF186 in related metabolic conditions.

Abstract

RNF186 regulates glucose metabolism across multiple tissues in MAFLD, notably by playing a dual role in modulating the transcription and translocation of GLUT4 in skeletal muscle. These findings suggest that targeting the expression of RNF186 could be a potential therapeutic strategy for treating MAFLD and related metabolic disorders.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Qizhang Du (2025) studied this question.

synapsesocial.com/papers/692e3d846c9b3ab28c1874bahttps://doi.org/10.1186/s13578-025-01507-6
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Sex- and age-associated factors drive the pathophysiology of MASLD2024 · 27 citations
  2. 2α-Actinin-4 Is Selectively Required for Insulin-induced GLUT4 Translocation2008 · 56 citations
  3. 3Skeletal muscle and MASLD: Mechanistic and clinical insights2025 · 53 citations
  4. 4Rare mutations associating with serum creatinine and chronic kidney disease2014 · 63 citations
  5. 5Globular adiponectin activates Akt in cultured myocytes2012 · 8 citations